Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 3.3M | 3.1M | 5.3M | 3.9M |
| General And Administrative Expense | 3.3M | 3.1M | 5.3M | 3.9M |
| Other Operating Expenses | 6.9M | 12.2M | 12.6M | 31.8M |
| Operating Expense | 11.0M | 16.8M | 24.8M | 38.0M |
| Operating Income | -11.0M | -16.8M | -24.8M | -38.0M |
| EBIT | -11.0M | -16.8M | -24.8M | -38.0M |
| Interest Income | 145,025 | 163,127 | 299,319 | -- |
| Interest Income Non Operating | 145,025 | 163,127 | 299,319 | -- |
| Net Interest Income | 145,025 | 163,127 | 299,319 | 52,218 |
| Other Income Expense | 1.3M | 9.0M | -10.1M | 6.1M |
| Other Non Operating Income Expenses | 1.4M | 6.1M | 6.5M | 6.1M |
| Special Income Charges | -91,686 | 2.9M | -16.5M | 0.00 |
| Write Off | 0.00 | 150,000 | 0.00 | -- |
| Gain On Sale Of Security | -38,395 | -- | -- | -- |
| Pretax Income | -9.5M | -7.6M | -34.6M | -31.9M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Income From Continuing Operation Net Minority Interest | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Income Including Noncontrolling Interests | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Income Common Stockholders | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Income | -9.5M | -7.6M | -34.6M | -31.9M |
| EBITDA | -10.1M | -15.9M | -23.8M | -36.6M |
| Normalized EBITDA | -9.9M | -18.8M | -7.2M | -36.6M |
| Reconciled Depreciation | 909,600 | 915,000 | 1.1M | 1.4M |
| Basic EPS | -0.06 | -0.06 | -0.28 | -0.31 |
| Diluted EPS | -0.06 | -0.06 | -0.28 | -0.31 |
| Basic Average Shares | 151.5M | 126.3M | 123.4M | 101.5M |
| Diluted Average Shares | 151.5M | 126.3M | 123.4M | 101.5M |
| Total Unusual Items | -130,081 | 2.9M | -16.5M | 0.00 |
| Total Unusual Items Excluding Goodwill | -130,081 | 2.9M | -16.5M | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -9.4M | -10.5M | -18.1M | -31.9M |
| Diluted NI Availto Com Stockholders | -9.5M | -7.6M | -34.6M | -31.9M |
| Gain On Sale Of Ppe | -91,686 | 3.0M | 0.00 | -- |
| Impairment Of Capital Assets | -- | 0.00 | 16.5M | 0.00 |
| Net Income Continuous Operations | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Non Operating Interest Income Expense | 145,025 | 163,127 | 299,319 | 52,218 |
| Other Gand A | 898,182 | 572,564 | 983,982 | 981,480 |
| Rent And Landing Fees | 65,975 | 70,421 | 66,100 | 74,332 |
| Rent Expense Supplemental | 65,975 | 70,421 | 66,100 | 74,332 |
| Salaries And Wages | 2.4M | 2.5M | 4.3M | 2.8M |
| Total Expenses | 11.0M | 16.8M | 24.8M | 38.0M |
| Total Other Finance Cost | -- | -- | -299,319 | -52,218 |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.2M | 2.8M | 7.4M | 4.5M |
| Cash Cash Equivalents And Short Term Investments | 1.2M | 2.9M | 7.5M | 4.5M |
| Cash Financial | 1.2M | 2.8M | 7.4M | 4.5M |
| Other Short Term Investments | 21,605 | 60,000 | 60,000 | 60,000 |
| Receivables | 1.2M | 1.5M | 3.0M | 2.1M |
| Prepaid Assets | 221,003 | 120,963 | 0.00 | -- |
| Current Assets | 3.2M | 4.5M | 10.4M | 6.6M |
| Gross PPE | 25.0M | 25.1M | 26.5M | 43.2M |
| Accumulated Depreciation | -6.6M | -5.8M | -6.1M | -5.2M |
| Net PPE | 18.4M | 19.4M | 20.4M | 38.0M |
| Total Non Current Assets | 21.0M | 22.4M | 22.1M | 39.7M |
| Total Assets | 24.2M | 26.9M | 32.6M | 46.4M |
| Current Debt | -- | -- | 51,740 | 64,243 |
| Current Debt And Capital Lease Obligation | -- | -- | 51,740 | 64,243 |
| Accounts Payable | 1.8M | 6.1M | 5.2M | 4.6M |
| Payables | 1.8M | 6.1M | 5.2M | 4.6M |
| Payables And Accrued Expenses | 2.6M | 7.0M | 6.6M | 5.3M |
| Current Accrued Expenses | 792,476 | 913,903 | 1.4M | 730,287 |
| Other Current Liabilities | 426,000 | -- | 3.9M | 3.0M |
| Current Liabilities | 3.0M | 7.0M | 10.6M | 8.4M |
| Long Term Debt | -- | -- | 645.00 | 52,385 |
| Long Term Debt And Capital Lease Obligation | -- | -- | 645.00 | 52,385 |
| Total Non Current Liabilities Net Minority Interest | 12.5M | 11.1M | 6.5M | 6.0M |
| Total Liabilities Net Minority Interest | 15.5M | 18.1M | 17.1M | 14.4M |
| Common Stock | 283.0M | 277.5M | 277.3M | 260.7M |
| Capital Stock | 283.0M | 277.5M | 277.3M | 260.7M |
| Retained Earnings | -299.3M | -289.7M | -282.1M | -247.5M |
| Common Stock Equity | 8.7M | 8.8M | 15.5M | 31.9M |
| Stockholders Equity | 8.7M | 8.8M | 15.5M | 31.9M |
| Total Equity Gross Minority Interest | 8.7M | 8.8M | 15.5M | 31.9M |
| Total Capitalization | 8.7M | 8.8M | 15.5M | 32.0M |
| Net Tangible Assets | 8.7M | 8.8M | 15.5M | 31.9M |
| Tangible Book Value | 8.7M | 8.8M | 15.5M | 31.9M |
| Working Capital | 200,830 | -2.5M | -140,357 | -1.7M |
| Invested Capital | 8.7M | 8.8M | 15.5M | 32.0M |
| Total Debt | -- | -- | 52,385 | 116,628 |
| Share Issued | 166.2M | 127.4M | 126.2M | 111.3M |
| Ordinary Shares Number | 166.2M | 127.4M | 126.2M | 111.3M |
| Long Term Provisions | 12.5M | 11.1M | 6.5M | 6.0M |
| Non Current Prepaid Assets | 2.6M | 3.0M | 1.7M | 1.7M |
| Other Equity Interest | 25.0M | 21.0M | 20.3M | 18.7M |
| Other Properties | 16.2M | 16.2M | 17.4M | 34.1M |
| Other Receivables | 576,912 | 282,544 | 339,428 | 45,686 |
| Restricted Cash | 588,973 | 0.00 | -- | -- |
| Taxes Receivable | 577,564 | 1.2M | 2.6M | 2.1M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -9.6M | -4.7M | -20.5M | -34.6M |
| Cash Flow From Continuing Operating Activities | -9.6M | -4.7M | -20.5M | -34.6M |
| Depreciation And Amortization | 909,600 | 915,000 | 1.1M | 1.4M |
| Depreciation Amortization Depletion | 909,600 | 915,000 | 1.1M | 1.4M |
| Stock Based Compensation | 795,765 | 710,000 | 1.7M | 1.9M |
| Change In Working Capital | -2.3M | 283,188 | 379,212 | 43,764 |
| Change In Receivables | 365,228 | 1.3M | -863,738 | -560,395 |
| Change In Inventory | -- | -- | 0.00 | 932,104 |
| Change In Payables And Accrued Expense | -2.9M | 410,749 | 1.2M | -539,993 |
| Change In Payable | -2.9M | 410,749 | 1.2M | -539,993 |
| Other Non Cash Items | 396,000 | 825,856 | -5.5M | -6.0M |
| Capital Expenditure | -- | -- | -128,525 | -53,127 |
| Purchase Of PPE | -- | -- | -128,525 | -53,127 |
| Net PPE Purchase And Sale | 0.00 | 200,200 | -128,525 | -53,127 |
| Investing Cash Flow | 0.00 | 200,200 | -128,525 | -53,127 |
| Cash Flow From Continuing Investing Activities | 0.00 | 200,200 | -128,525 | -53,127 |
| Repayment Of Debt | 0.00 | -52,385 | -64,243 | -604,030 |
| Net Issuance Payments Of Debt | 0.00 | -52,385 | -64,243 | -604,030 |
| Issuance Of Capital Stock | 9.0M | 0.00 | 25.0M | 29.1M |
| Net Common Stock Issuance | 9.0M | 0.00 | 25.0M | 29.1M |
| Financing Cash Flow | 8.0M | -52,385 | 23.6M | 26.7M |
| Cash Flow From Continuing Financing Activities | 8.0M | -52,385 | 23.6M | 26.7M |
| Changes In Cash | -1.6M | -4.6M | 2.9M | -8.0M |
| Beginning Cash Position | 2.8M | 7.4M | 4.5M | 12.4M |
| End Cash Position | 1.2M | 2.8M | 7.4M | 4.5M |
| Free Cash Flow | -9.6M | -4.7M | -20.7M | -34.6M |
| Interest Paid Supplemental Data | 15,454 | 9,552 | 3,609 | 26,089 |
| Asset Impairment Charge | 0.00 | 150,000 | 16.5M | 0.00 |
| Change In Account Payable | -- | -- | -- | -539,993 |
| Change In Prepaid Assets | 250,433 | -1.4M | 1,300 | 212,048 |
| Common Stock Issuance | 9.0M | 0.00 | 25.0M | 29.1M |
| Depreciation | 909,600 | 915,000 | 1.1M | 1.4M |
| Gain Loss On Investment Securities | -- | -- | -- | -40,000 |
| Gain Loss On Sale Of PPE | 91,686 | -28,635 | 0.00 | -- |
| Long Term Debt Payments | 0.00 | -52,385 | -64,243 | -604,030 |
| Net Income From Continuing Operations | -9.5M | -7.6M | -34.6M | -31.9M |
| Net Long Term Debt Issuance | 0.00 | -52,385 | -64,243 | -604,030 |
| Net Other Financing Charges | -1.0M | -- | -1.6M | -1.9M |
| Operating Gains Losses | 91,686 | -28,635 | -- | -40,000 |
| Proceeds From Stock Option Exercised | -- | 0.00 | 174,000 | 0.00 |
| Sale Of PPE | 0.00 | 200,200 | -- | -- |
| Unrealized Gain Loss On Investment Securities | 38,395 | 0.00 | -- | -- |